MMS

Did you know that one of the most common reasons for study failures is poor management of data, or a lack of focus on biometrics? When Biometrics is not treated as a core specialty, delays and errors accumulate quickly. Or even worse, important signals of issues across the entire study delivery landscape can be missed. Learn about the path to a successful transition here: https://hubs.li/Q02_TsK90 #pharma #biotech #clinicalresearch

It’s tomorrow! Join us at the 17th Annual Outsourcing in Clinical Trials West Coast conference. Comment “I’ll be there” if you plan on attending. We’ll be in the main hall, discussing: ➡️Strategic regulatory support, including Fast Track and RTOR ➡️Advanced biometrics and data visualization with Datacise® ➡️Comprehensive solutions for medical writing, pharmacovigilance, mock inspections, QC, and more! MMS is a true partner that cares about your data. Schedule a meeting now: https://hubs.ly/Q035XvH90 See you tomorrow! #OCTWestCoast #ClinicalTrials #Outsourcing #Biometrics #Pharma #Biotech #DrugDevelopment

New Regulatory Intelligence is available focused on the FDA's protocol deviation guidance and our perspectives on planning for the things that don’t go according to plan! Read the full update here: https://hubs.li/Q035LB-P0 #drugdevelopment #fda #biotech #pharma #regulatorystrategy #medicalwriting

Key FDA programs that can transform timelines for oncology therapies, including Real-Time Oncology Review (RTOR) and Project Orbis were the center of discussion during a recent talk from MMS experts. Now in an on-demand webinar format, MMS shares several strategies for success in expedited oncology pathways, like: 💡 Plan early and align often with the FDA 💡 Integrate data, process, and strategy 💡 Build compliance into your roadmap 💡 Prioritize benefit-risk assessment at every stage Access the full webinar on-demand by filling out the form here: https://hubs.li/Q035n4qT0 #Oncology #ClinicalResearch #RegulatoryAffairs #FDA #ProjectOrbis #RTOR #Pharma #Biotech

Attention all passionate Medical Writers! We have vital roles open across all levels of medical writing expertise globally. Apply now if you want to: ✅ Thrive in a collaborative, dynamic environment where your work makes a difference ✅ Grow with a team that values excellence, innovation, and leadership ✅ Work on diverse, meaningful projects across multiple therapeutic areas Explore open positions and start your journey with MMS: https://hubs.li/Q0358Nhm0 #MedicalWriting #MedicalWriter #ClinicalResearch #OneMMS #PharmaJobs #WritingJobs

Since launch, the Oncology Center of Excellence (OCE) Real-time Oncology Review (RTOR) Pilot Program has been accelerating the review of new oncology treatments. While it offers earlier FDA engagement and quicker development times, challenges include managing frequent IRs with tight turnaround times and impact on future submissions, as well as complex planning with the need to coordinate rolling submissions with rapid review cycles. MMS has a significant amount of experience in RTORs, and can support: ➡️ FDA Alignment: Develop a feasible RTOR plan with aggressive timelines. ➡️ Optimized Planning: Ensure rapid and compliant submissions. ➡️ Efficient Data Management: Tailored plans for your program. ➡️ Timely IR Responses: Quick and effective IR management. Read more on the topic to accelerate your oncology submissions here: https://hubs.li/Q034F1j_0 #Oncology #RTOR #FDA #DrugDevelopment April Ben Swathi Raksha

February is American Heart Month, and MMS has helped make significant strides in the cardiovascular arena! ❤️ While heart disease remains a leading cause of death worldwide, MMS is proud to support drug development efforts that have contributed to potentially life-saving cardiovascular treatments in the areas of hypertension, dyslipidemia, heart failure, coronary artery disease, stroke, thrombosis, and others. This month, let’s all work to inspire healthier choices, drive meaningful research, and support better outcomes for patients everywhere. How are you taking care of your heart this month? Share your tips in the comments below and learn about our full scope of therapeutic expertise at https://hubs.li/Q034Rzd40 #AmericanHeartMonth #HeartHealth #ClinicalResearch #Cardiovascular #Pharma #Biotech #OneMMS

MMS will be in San Francisco for the 17th Annual Outsourcing in Clinical Trials West Coast 2025 conference next month! Are you looking for a partner whose successful outcomes for our customers come to life through having the best customer satisfaction and employee stability in the industry? If so, visit us to ✅ Discuss our full-service biometrics and regulatory submissions solutions ✅ Hear how cutting-edge technologies like Datacise® can support your data-driven decision-making ✅ Learn how a sense of urgency and leadership (SOUL) drives our culture for better outcomes Schedule a meeting in advance to connect with our team! Learn more about MMS at: https://hubs.li/Q034F3z10 #OCTWestCoast #ClinicalTrials #Outsourcing #Biometrics #Pharma #Biotech #DrugDevelopment

This year, MMS Associate Manager of Regulatory and Medical Writing Arshi Ghousia will take on a speaking role as a thought leader at the annual Indian Society for Clinical Research (ISCR) 2025 Conference in Mumbai this year! Ghousia will give a thought-provoking presentation, titled “Role of Medical Writing in Patient-Centric Documents that Support the Success of Clinical Trials in India.” This is expected to occur during a pre-conference workshop on January 31st between 2-5pm local time. To connect with her or Priya Roy, Ph.D., Team Lead in Clinical Trial Disclosure, during ISCR 2025, fill out the following form and we'll be in touch: https://lnkd.in/drmhuWW2 #ISCR2025 #OneMMS #MedicalWriting

January 28th is Data Privacy Day! How do you prioritize data privacy in your work? Share your insights in the comments! At MMS, we recognize that protecting data is our responsibility, and as data becomes increasingly complex, our commitment to safeguarding privacy grows stronger every day to ensure the integrity of every project and the confidence of every stakeholder. Learn about our commitment to strive for good science and strong processes at https://hubs.li/Q034g_nb0. #DataPrivacyDay #ClinicalResearch #DataIntegrity #Pharma #Biotech